Spohn H E, Coyne L, Spray J
Menninger Foundation, Topeka, KS 66601.
Arch Gen Psychiatry. 1988 Sep;45(9):833-40. doi: 10.1001/archpsyc.1988.01800330059007.
We sought to determine whether such state-related factors as neuroleptic treatment and facio-oral tardive dyskinesia (TD) influence smooth-pursuit eye movement (SPEM) in chronic schizophrenics. The design involved 100 schizophrenics, 64 of whom showed "abnormal" eye tracking. Experimentally drug-withdrawn patients, some of whom were clinically relapsed, were compared with control patients who continued taking medication in prewithdrawal and postwithdrawal SPEM tests. All groups showed a slight worsening in eye-tracking performance on two postwithdrawal tests, but significant group-by-test session "interactions" were not demonstrable. We also determined that patients with TD tend to substitute large, nontracking saccades for SPEM to a significantly greater extent than nondyskinetic patients. Our findings strengthen the supposition that impaired SPEM is a trait in many schizophrenics but suggest that patients with TD be excluded in future studies of SPEM addressed to trait issues.
我们试图确定诸如抗精神病药物治疗和面部口部迟发性运动障碍(TD)等与状态相关的因素是否会影响慢性精神分裂症患者的平稳跟踪眼球运动(SPEM)。该研究设计涉及100名精神分裂症患者,其中64名表现出“异常”的眼球跟踪。将实验性停药的患者(其中一些在临床上复发)与在停药前和停药后的SPEM测试中继续服药的对照患者进行比较。所有组在两次停药后的测试中眼球跟踪表现均略有恶化,但未显示出显著的组×测试阶段“交互作用”。我们还确定,与无运动障碍的患者相比,患有TD的患者更倾向于用大的、非跟踪性扫视替代SPEM。我们的研究结果强化了这样一种假设,即SPEM受损是许多精神分裂症患者的一种特质,但表明在未来针对特质问题的SPEM研究中应排除患有TD的患者。